Guided Therapeutics (GTHP) FCF Payout Ratio (2023 - 2024)
Guided Therapeutics (GTHP) reported FCF Payout Ratio of 0.26 for Q2 2024, up 60.77% sequentially from 0.65 in Q1 2024.
Guided Therapeutics (GTHP) FCF Payout Ratio (2023 - 2024) Analysis & Trends
Guided Therapeutics (GTHP) has 2 years of FCF Payout Ratio data on file, last reported at 0.26 in Q2 2024.
- For the quarter ending Q2 2024, FCF Payout Ratio changed N/A year-over-year to 0.26; the trailing twelve-month figure through Jun 2024 stood at 0.11 (down 209.28% YoY), and the FY2023 full-year result was 0.04, up 52.99% from the prior year.
- FCF Payout Ratio advanced to 0.26 in Q2 2024, from 0.65 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 0.13 in Q1 2023 to a low of 0.65 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.14 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.65 |
| Mar 31, 2023 | -0.13 |